13F

Stock

HCW Biologics Inc.

HCWB · held by 15 managers

Reported value

$48.9K

Holders

15

+5 new · −5 exited

Holders’ est. mark

−$32.6K

Price effect on 8 books still in the name

Largest holder

$12.9K

GEODE CAPITAL MANAGEMENT, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC35.9K$12.9K−$8.57KCut−$706
Citadel26.1K$9.39K−$13.5KCut−$12.1K
Tower Research Capital LLC (TRC)14.8K$5.34K−$2.75KAdded$970
JANE STREET GROUP, LLC14.1K$5.09KNew
VANGUARD CAPITAL MANAGEMENT LLC12K$4.33KHeld
CITIGROUP INC10.5K$3.79K−$1Added$3.79K
Golden State Wealth Management, LLC10K$3.6K−$6.11KCut−$6.11K
UBS Group AG9.22K$3.32K−$1.06KAdded$1.63K
VANGUARD FIDUCIARY TRUST CO1.9K$685Held
WELLS FARGO & COMPANY/MN1K$360−$611Cut−$611
HRT FINANCIAL LP266.4K$95New
Virtu Financial LLC47.8K$17New
OSAIC HOLDINGS, INC.26$9−$16Cut−$16
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO2$1New
SBI Securities Co., Ltd.1$0New

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.